| Identification | Back Directory | [Name]
contulakin G | [CAS]
229180-41-0 | [Synonyms]
contulakin G
Thr10contulakin-G
L-Leucine, 5-oxo-L-prolyl-L-seryl-L-α-glutamyl-L-α-glutamylglycylglycyl-L-seryl-L-asparaginyl-L-alanyl-O-[2-(acetylamino)-2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranosyl]-L-threonyl-L-lysyl-L-lysyl-L-prolyl-L-tyrosyl-L-isoleucyl- | [Molecular Formula]
C88H140N20O37 | [MOL File]
229180-41-0.mol | [Molecular Weight]
2070.19 |
| Hazard Information | Back Directory | [Uses]
Contulakin G is an O-glycosylated invertebrate neurotensin. Contulakin-G is a weaker agonist for the neurotensin receptor. Contulakin G is also a potent antinociceptive agent[1][2]. | [in vivo]
Contulakin G exhibits potent analgesic activity in three pain models in rats following intrathecal delivery, namely in tail-flick (acute pain), formalin test, and CFA-induced allodynia inflammatory pain[1].
Contulakin G (0-3 nmoL, Intrathecally) significantly decreases flinching behavior in rats[2].
Contulakin G (50-500 nmoL, Intrathecally) produces a dose-dependent increase in the thermally evoked skin twitch latency by 30 min after administration in dogs[2]. | Animal Model: | Male Holtzman rats (300-375 g)[2] | | Dosage: | 0.03, 0.1, 0.3, and 3 nmol | | Administration: | Intrathecally, administered as a 10-μL bolus followed by a 10-μL saline flush | | Result: | Produced a significant decrease in flinching in all phases of the formalin test in rats. |
| Animal Model: | Purpose-bred beagle dogs (9-12 kg)[2] | | Dosage: | 50, 150, or 500 nmol | | Administration: | Intrathecally | | Result: | Produced a dose-dependent increase in the thermally evoked skin twitch latency at 30 min after dosing in dogs, which reached statistical difference as compared to vehicle at 500 nmol. |
| [References]
[1] Lee HK, et al. A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties. Front Pharmacol. 2015 Feb 10;6:11. DOI:10.3389/fphar.2015.00011
[2] Allen JW, et al. An assessment of the antinociceptive efficacy of intrathecal and epidural contulakin-G in rats and dogs. Anesth Analg. 2007 Jun;104(6):1505-13, table of contents. DOI:10.1213/01.ANE.0000219586.65112.FA |
|
| Company Name: |
Alomone Labs
|
| Tel: |
4008-168-068 13121892008 |
| Website: |
www.alomone.com |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|